Physician profile
Chase Jett Wehrle
NPI 1962081141
$741,343.52
in general payments reported to CMS, 2019-2025
10 companies · $739K in 2025
The $739K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.26 · 2022: $26.42 · 2023: $131 · 2024: $1,874 · 2025: $739K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $406K · Acquisitions: $316K · Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,593 · Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $406,132.45 |
| Acquisitions | $315,993.89 |
| Travel and Lodging | $12,220.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,593.19 |
| Food and Beverage | $2,346.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $735,253.92 | 2024-2025 | |
| Novo Nordisk INC | $4,631.39 | 2024-2025 | Wegovy |
| Dilon Technologies, INC. | $476.13 | 2023-2025 | Hemoblast Bellows |
| Mimedx Group, INC. | $271.58 | 2024 | |
| Ethicon US, LLC | $235.33 | 2024-2025 | Echelon; Endopath, Stratafix, Evarrest |
| Integra Lifesciences Corporation | $175.10 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intera Oncology, INC | $149.99 | 2025 | Intera |
| Organox Ltd | $96.71 | 2025 | |
| Intuitive Surgical, INC. | $30.26 | 2021 | |
| Merck Sharp & Dohme LLC | $23.11 | 2024 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Wehrle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.